Pharmaceuticals & Drugs
|Market Cap||349 Cr||EPS||59.6||High||625|
|Stock P/E||10.2||Net Profit Margin||NA||Low||595.4|
|Market Cap||349 Cr||ROE||13.5%|
|P/B Ratio||1.2||Dividend Yield||1.5%|
|Industry P/E||64.4||Book Value||519.1|
About the Company
Albert David was incorporated in the year 1938. The company is a part of Kothari group.
Albert David, which has decades of illustrious presence in the health care industry, manufactures pharmaceutical formulations and bulk drugs, infusion solutions and oral solids, disposable syringes and needles and herbal formulations. The company exports these products to Vietnam, Russia, Belarus, Egypt, Bangladesh, Kenya, Tanzania, Uganda, Sudan, Ethiopia, Nigeria, Zaire, Haiti, Brazil, Canada, USA, UK, Netherlands and Germany as the company is a WHO-approved supplier.
It also has DMF for the bulk drugs, Tolbutamide and Chlorpropamide with the US Food and Drugs Administration (USFDA). The manufacturing facility for these products has been inspected and validated by the US drug regulator.
The manufacturing plants of the company are located at Ghaziabad near New Delhi, Kolkata and Mandideep near Bhopal.
The company`s amino acid range under the brand name of Alamin contains pure crystalline amino acid of high international standards manufactured under a unique technology, which conforms to WHO and FAO recommendations. In the herbal segment, the company sells its products under brand names like Adliv, which is a hepato protective and Siotone capsule, which is the only adaptogen indicated for stress.
ADL has tie-ups with Ajinomoto Co and Roussel Morishita Co of Japan for manufacturing and marketing a wide range of crystalline amino acid infusion solutions, oral solids and liquids in India.
Products offered by the Company:
The company is operating in major therapeutic segments that include:
The company will explore the possibilities for export of its IV fluids, small volume parenterals and disposable syringes in addition to its existing range.
|Parent Organisation||Albert David Ltd.||Managing Director|
|Company||52 Week||Market Price||P/E Ratio|
Frequently asked questions